Abstract:OBJECTIVES:Low levels of vitamin D are associated with a higher mortality in cirrhotic patients, but the role of this deficiency is still unknown. The purpose of this study was to assess the levels of vitamin D in cirrhotic patients with and without bacterial infection.METHODS:25-hydroxy (25-OH) vitamin D was assessed by immunoassay in 88 patients hospitalized in our hepatology unit.RESULTS:The causes of cirrhosis were mainly alcohol (70%), hepatitis C (10%), or both (9%). Infections (n=38) mainly included bac… Show more
“…A deleterious impact of the lack of vitamin D on the immune system is possible during severe chronic liver diseases (Iruzubieta et al, 2014). We have previously shown, in a cohort of mainly alcoholic cirrhotic patients, that a severe deficiency in 25-OH vitamin D was associated with an increased risk of bacterial infection independently of the Child-Pugh score (Anty et al, 2014).…”
“…A deleterious impact of the lack of vitamin D on the immune system is possible during severe chronic liver diseases (Iruzubieta et al, 2014). We have previously shown, in a cohort of mainly alcoholic cirrhotic patients, that a severe deficiency in 25-OH vitamin D was associated with an increased risk of bacterial infection independently of the Child-Pugh score (Anty et al, 2014).…”
“…Vitamin D insufficiency was not an independent risk factor for mortality in logistic regression analysis (OR= 1.8 95% CI 0.554-5.863, p = 0.328), thus Vitamin D insufficiency may be a helper but not a real risk factor for mortality Significant association between Vitamin D levels and illness severity on admission: SOFA Score: insufficiency: 8 (6-11), sufficiency: 6 (4-9), p = 0.005 APACHE II Score: insufficiency: 24 (19)(20)(21)(22)(23)(24)(25)(26)(27)(28) Multiple-regression model using variables that significantly correlated with admission FIM score (age, grip strength, and body weight): only serum 25OHD was a significant contributor (p = 0.02) to the multiple r value (multiple r = 0.42, p = 0.001).…”
Section: Prevalence Of Vitamin D Deficiency and Insufficiencymentioning
confidence: 97%
“…23 The incidence of bacterial infections in cirrhotic patients has been found to not be associated with vitamin D levels. 22 Only one study looked at intensive care unit (ICU) admission rates and found a significant inverse relationship with vitamin D levels. 19 An investigation of a correlation between vitamin D levels and length of hospital stay showed contradicting results.…”
Section: Secondary Endpoints: Infections and Other Health Outcomesmentioning
confidence: 99%
“…20 Four studies did not find a significant correlation between vitamin D deficiency and mortality. All studied a specific subgroup of medical inpatients: those with Clostridium difficile infections, 21 hepatic cirrhosis, 22 CAP, 23 or acute kidney injury. 24 …”
Despite evidence of associations in observational studies, high-quality evidence from interventional trials on the benefits of vitamin D supplementation in inpatients is currently lacking. On the basis of the available evidence, general vitamin D screening and supplementation for the medical inpatient population in an acute care setting cannot be recommended.
“…It was found that a low level of vitamin D was independently associated with an increased risk of bacterial infection in patients with cirrhosis (10); however, the exact mechanism is unclear.…”
When vitamin D levels were low, bacteria inhibited VDR and LL-37 responses in peritoneal macrophages as a mechanism to evade antibacterial defence. Vitamin D supplementation could up-regulate peritoneal macrophage VDR and LL-37 expressions, which resulted in an enhanced immunological defence against SBP in patients with cirrhosis and ascites.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.